Search Results for "Drug Interactions"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug Interactions. Results 71 to 80 of 1090 total matches.
Correction: Two New Drugs for Weight Loss
The Medical Letter on Drugs and Therapeutics • Sep 17, 2012 (Issue 1399)
in the “Drug Interactions” paragraph, the last sentence
should read: “Phentermine is contraindicated while ...
(Med Lett Drugs Ther 2012; 54:69) On page 71 in the "Drug Interactions" paragraph, the last sentence should read: "Phentermine is contraindicated while taking, and for 14 days after stopping, a monoamine oxidase (MAO) inhibitor because of the risk of hypertensive crisis."
Correction: A 4-Drug Combination (Stribild) for HIV
The Medical Letter on Drugs and Therapeutics • Jan 21, 2013 (Issue 1408)
)
On page 95 in the “Drug Interactions” paragraph, the word
“oral” should have been added before “midazolam ...
On page 95 in the "Drug Interactions" paragraph (Med Lett Drugs Ther 2012; 54:95), the word "oral" should have been added before "midazolam" in the 3rd sentence. Stribild is contraindicated with oral midazolam.
Two New Drugs for Renal Cell Carcinoma
The Medical Letter on Drugs and Therapeutics • Feb 26, 2007 (Issue 1255)
,
which occurred in animal studies, was uncommon in
clinical trials.
Drug Interactions – Sunitinib ...
Sunitinib (Sutent - Pfizer) and sorafenib (Nexavar - Bayer), two oral tyrosine kinase inhibitors, have been approved by the FDA for treatment of advanced renal cell carcinoma (RCC). Sunitinib is also approved for use in patients with gastrointestinal stromal tumor (GIST) who are not responding to or are intolerant of standard therapy with imatinib (Gleevec).
Drugs for Opioid Use Disorder
The Medical Letter on Drugs and Therapeutics • Sep 04, 2023 (Issue 1684)
.
Drug Interactions – Methadone is a substrate of
CYP3A4 and CYP2B6; inhibitors of these isozymes ...
Opioid use disorder is a chronic, relapsing disease with
physical and psychiatric components. It is associated
with economic hardship, social isolation, incarceration,
increased rates of blood-borne infections such as HIV
and viral hepatitis, adverse pregnancy outcomes, and
increased mortality. According to the NIH, there were
80,411 deaths involving an opioid in the US in 2021,
more than in any previous year. Several guidelines on
the management of opioid use disorder are available;
all recommend maintenance pharmacotherapy as the
standard of care.
Med Lett Drugs Ther. 2023 Sep 4;65(1684):137-44 doi:10.58347/tml.2023.1684a | Show Introduction Hide Introduction
Drugs for Pneumonia
Treatment Guidelines from The Medical Letter • Sep 01, 2003 (Issue 13)
adverse interactions with
other drugs. Azithromycin has fewer interactions.
Erythromycin ...
The choice of drugs for treatment of pneumonia depends on the most likely pathogens causing the infection and local antimicrobial resistance patterns. Factors such as severity of illness, presence of co-morbid conditions and whether the infection is community or hospital-acquired also need to be considered.
Drugs and Devices for Weight Management
The Medical Letter on Drugs and Therapeutics • May 30, 2022 (Issue 1651)
in Table 4.
Drug Interactions – Use of sympathomimetic amines
are contraindicated with or within 14 days ...
Adults with a body mass index (BMI) between 25
and 29.9 kg/m2 are considered overweight. Those
with a BMI ≥30 are considered obese. The initial
recommendation for any weight loss effort is to
achieve a 5-10% reduction in weight, which has been
associated with a reduction in the risk of developing
type 2 diabetes, hypertension, and dyslipidemia. Diet,
exercise, and behavior modification are the preferred
methods for losing weight, but long-term weight
maintenance can be difficult. Several drugs and
devices are FDA-approved for weight reduction and
maintenance of weight...
Cardiovascular Drugs in the ICU
Treatment Guidelines from The Medical Letter • Dec 01, 2002 (Issue 4)
, amphetamine
toxicity, clonidine withdrawal, monoamine oxidase
drug interactions and pheochromocytoma ...
Ever-increasing specialization has made it difficult for many physicians to keep up with therapeutic standards in intensive-care units (ICUs). This issue of Treatment Guidelines offers current recommendations for use of cardiovascular drugs in the ICU for treatment of hypertensive emergencies; shock, cardiac arrest or decompensated heart failure; and ventricular arrhythmias.
Three New Drugs for HIV Infection
The Medical Letter on Drugs and Therapeutics • Dec 04, 1998 (Issue 1041)
Interactions — Efavirenz induces CYP3A4 and may decrease serum levels of drugs
metabolized by the enzyme ...
Combination antiretroviral therapy including protease inhibitors has dramatically changed the treatment of HIV infection and the prognosis of those affected (Medical Letter Handbook of Antimicrobial Therapy, 1998, page 122). Due to limitations and failures with these drugs in many patients, however, three new drugs, none of them protease inhibitors, have rapidly come into wide use in clinical trials or 'expanded access' programs. They are abacavir (Ziagen - Glaxo Wellcome), adefovir (Preveon - Gilead) and efavirenz (Sustiva - DuPont). Efavirenz was recently approved for treatment of...
Molnupiravir - An Oral Antiviral Drug for COVID-19
The Medical Letter on Drugs and Therapeutics • Jan 24, 2022 (Issue 1642)
SARS-CoV-2 variants.
DRUG INTERACTIONS ― No clinically significant drug
interactions ...
The investigational oral antiviral drug molnupiravir
(Merck/Ridgeback Biotherapeutics) was granted an
FDA Emergency Use Authorization (EUA) on December
23, 2021 for treatment of mild to moderate COVID-19
in outpatients ≥18 years old who are at high risk of
progressing to severe disease, including hospitalization
or death (see Table 1), and for whom alternative treatment options are
not available or clinically appropriate. Paxlovid (Pfizer),
nirmatrelvir copackaged with ritonavir, was granted
an EUA on December 22, 2021. The IV antiviral drug
remdesivir (Veklury) was approved by the...
Some Drugs for COVID-19
The Medical Letter on Drugs and Therapeutics • Apr 06, 2020 (Issue 1595)
to interact adversely with many drugs.14 The NIH and the Society of Critical Care Medicine recommend against ...
The severity and rapid spread of COVID-19 (caused by SARS-CoV-2) have raised questions about the use of some drugs in patients with the disease and whether currently available drugs could be effective in treating it. Definitive answers are lacking, but some recommendations can be made. For additional information on specific drugs, see our table Some Drugs Being Considered for Treatment of COVID-19.